Lamisil

Terbinafine Hydrochloride, the active ingredient in Lamisil, is an allylamine antifungal presented as a topical formulation for skin application. It is indicated for the treatment of superficial dermatophytosis, including athlete’s foot (tinea pedis), ringworm (tinea corporis), and jock itch (tinea cruris) in both adults and children.

GNH USA supplies Lamisil as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring consistent quality and regulatory compliance across markets through a robust supply chain and comprehensive documentation plus reliable logistics.

Lamisil (terbinafine) is an allylamine antifungal that targets dermatophyte infections of the skin.

Tinea pedis: reduces fungal growth and clears symptoms of athlete’s foot. Tinea corporis: treats ringworm lesions on the body. Tinea cruris: resolves jock itch caused by dermatophytes.

Topical terbinafine may cause local or systemic adverse reactions.

Common Side Effects: - Application site itching - Redness or irritation - Burning sensation - Dryness of skin - Scaling - Mild rash

Serious or Rare Side Effects: - Severe allergic reaction (anaphylaxis) - Contact dermatitis - Liver enzyme elevation (rare systemic absorption) - Bullous skin lesions - Photosensitivity

Use of Lamisil should be considered in the context of patient‑specific factors and proper storage. - Pregnancy: consult a healthcare provider before use. - Breastfeeding: discuss potential risks with a professional. - Age: safety not established in children under 2 years. - Concomitant skin conditions: avoid application on damaged skin. - Allergy: discontinue if hypersensitivity occurs. - Store at room temperature: keep in original container, protect from moisture and light.

Terbinafine may interact with other agents; awareness of interaction severity is important.

Major Interactions (Avoid): - Strong CYP450 inhibitors: may increase systemic exposure. - Concurrent use of other topical antifungals: risk of additive irritation. - Systemic terbinafine: avoid simultaneous use to prevent overdose.

Moderate Interactions (Monitor Closely): - Alcohol: may increase liver enzyme risk if systemic absorption occurs. - Hepatotoxic drugs: monitor liver function during combined therapy. - Warfarin: potential for increased anticoagulant effect; monitor INR.